Thx.
So ideally by end of Q3 we will know if our trial design is approved by PDCO or if it needs further adjustments.
So its not EMA approval in Q3 but shortly after (fingers crossed). Nevertheless, since PDCO is assigned by EMA, one can assume the EMA approval afterwards is merely a formality.
